Pharmaceutical Products Companies By Enterprise Value
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Valuation
| Current Valuation | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | NEUP | Neuphoria Therapeutics | 0.15 | 5.91 | 0.90 | ||
| 2 | MDGL | Madrigal Pharmaceuticals | 0.04 | 4.27 | 0.17 | ||
| 3 | MRNA | Moderna | (0.04) | 5.33 | (0.24) | ||
| 4 | TLX | Telix Pharmaceuticals Limited | 0.05 | 3.20 | 0.16 | ||
| 5 | MTSR | Metsera, Common Stock | 0.16 | 8.84 | 1.38 | ||
| 6 | FBIOP | Fortress Biotech Pref | (0.02) | 2.76 | (0.05) | ||
| 7 | MRUS | Merus BV | 0.05 | 2.64 | 0.14 | ||
| 8 | MIRM | Mirum Pharmaceuticals | 0.08 | 2.50 | 0.21 | ||
| 9 | VCEL | Vericel Corp Ord | (0.13) | 2.53 | (0.32) | ||
| 10 | MLTX | MoonLake Immunotherapeutics | (0.15) | 2.81 | (0.42) | ||
| 11 | VKTX | Viking Therapeutics | (0.12) | 4.75 | (0.59) | ||
| 12 | MESO | Mesoblast | (0.23) | 3.73 | (0.85) | ||
| 13 | AAPG | Ascentage Pharma Group | 0.15 | 3.55 | 0.54 | ||
| 14 | MNKD | MannKind Corp | (0.22) | 1.85 | (0.40) | ||
| 15 | DNLI | Denali Therapeutics | (0.09) | 4.54 | (0.40) | ||
| 16 | DVAX | Dynavax Technologies | 0.08 | 1.49 | 0.11 | ||
| 17 | VERA | Vera Therapeutics | (0.17) | 3.90 | (0.65) | ||
| 18 | NWBO | Northwest Biotherapeutics | (0.05) | 3.57 | (0.20) | ||
| 19 | MLYS | Mineralys Therapeutics, Common | 0.07 | 7.34 | 0.49 | ||
| 20 | VALN | Valneva SE ADR | 0.19 | 5.21 | 0.97 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.